Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes

Journal of Virology

Volumn 89, Issue 5, 2015, Pages 2884-2891

  Eichholz, Karsten ^a,b   Mennechet, Franck J D ^a,b   Kremer, Eric J ^a,b  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4; BLOOD CLOTTING FACTOR 10; TLR4 PROTEIN, HUMAN;

ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; HUMAN COAGULATION FACTOR X ADENOVIRUS TYPE 5; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOLECULAR DYNAMICS; MONONUCLEAR PHAGOCYTE; NONHUMAN; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS IDENTIFICATION; CELL CULTURE; HUMAN ADENOVIRUS C; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PHAGOCYTE;

ANIMALIA; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; MURINAE; VERTEBRATA;

ADENOVIRUSES, HUMAN; CELLS, CULTURED; FACTOR X; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; PHAGOCYTES; TOLL-LIKE RECEPTOR 4;

EID: 84923007172     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03576-14     Document Type: Article

References (63)

1. Soudais C, Skender N, Kremer EJ. 2004. Long-term in vivo transduction of neurons throughout the rat central nervous system using novel helperdependent CAV-2 vectors. FASEB J 18:391-393. http://dx.doi.org/10.1096/fj.03-0438fje.
2. Cubizolle A, Serratrice N, Skander N, Colle M-A, Ibanes S, Gennetier A, Bayo-Puxan N, Mazouni K, Mennechet F, Joussemet B, Cherel Y, Lajat Y, Vite C, Bernex F, Kalatzis V, Haskins ME, Kremer EJ. 2014. Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain. Mol Ther 22:762-773. http://dx.doi.org/10.1038/mt.2013.283.
3. Perreau M, Pantaleo G, Kremer EJ. 2008. Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J Exp Med 205:2717-2725. http://dx.doi.org/10.1084/jem.20081786.
4. Barlan A, Griffin TM, McGuire KA, Wiethoff CM. 2011. Adenovirus membrane penetration activates the NLRP3 inflammasome. J Virol 85: 146-155. http://dx.doi.org/10.1128/JVI.01265-10.
5. Barlan A, Danthi P, Wiethoff CM. 2011. Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology 412:306-314. http://dx.doi.org/10.1016/j.virol.2011.01.019.
6. Schulte M, Sorkin M, Al-Benna S, Stupka J, Hirsch T, Daigeler A, Kesting MR, Steinau H-U, Jacobsen F, Steinstraesser L. 2013. Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and MDA5. Springerplus 2:234-240. http://dx.doi.org/10.1186/2193-1801-2-234.
7. Shay T, Jojic V, Zuk O, Rothamel K, Puyraimond-Zemmour D, Feng T, Wakamatsu E, Benoist C, Koller D, Regev A. 2013. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad SciUSA110:2946-2951. http://dx.doi.org/10.1073/pnas.1222738110.
8. Mestas J, Hughes CCW. 2004. Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731-2738. http://dx.doi.org/10.4049/jimmunol.172.5.2731.
9. Vaure C, Liu Y. 2014. A comparative review of Toll-like receptor 4 expression and functionality in different animal species. Front Immunol 5:316. http://dx.doi.org/10.3389/fimmu.2014.00316.
10. Doronin K, Flatt JW, Di Paolo NC, Khare R, Kalyuzhniy O, Acchione M, Sumida JP, Ohto U, Shimizu T, Akashi-Takamura S, Miyake K, MacDonald JW, Bammler TK, Beyer RP, Farin FM, Stewart PL, Shayakhmetov DM. 2012. Coagulation factor X activates innate immunity to human species C adenovirus. Science 338:795-798. http://dx.doi.org/10.1126/science.1226625.
11. Morelli AE, Larregina AT, Raymond W, Zahorchak AF, Plowey JM, Logar AJ, Robbins PD, Falo LD, Thomson AW, Ganster RW. 2000. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway. J Virol 74:9617-9628. http://dx.doi.org/10.1128/JVI.74.20.9617-9628.2000.
12. Philpott NJ, Nociari M, Elkon KB, Falck-Pedersen E. 2004. Adenovirusinduced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway. Proc Natl Acad Sci USA 101:6200-6205. http://dx.doi.org/10.1073/pnas.0308368101.
13. Seiradake E, Henaff D, Wodrich H, Billet O, Perreau M, Hippert C, Mennechet F, Schoehn G, Lortat-Jacob H, Dreja H, Ibanes S, Kalatzis V, Wang JP, Finberg RW, Cusack S, Kremer EJ. 2009. The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog 5:e1000277. http://dx.doi.org/10.1371/journal.ppat.1000277.
14. Lyons M, Onion D, Green NK, Aslan K, Rajaratnam R, Bazan-Peregrino M, Phipps S, Hale S, Mautner V, Seymour LW, Fisher KD. 2006. Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol Ther 14:118-128. http://dx.doi.org/10.1016/j.ymthe.2006.01.003.
15. Alemany R, Suzuki K, Curiel DT. 2000. Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 81(Pt 11):2605-2609.
16. Reid T, Warren R, Kirn D. 2002. Intravascular adenoviral agents in cancer patients: lessons from clinical trials. Cancer Gene Ther 9:979-986. http://dx.doi.org/10.1038/sj.cgt.7700539.
17. Reid T, Galanis E, Abbruzzese J, Sze D, Wein LM, Andrews J, Randlev B, Heise C, Uprichard M, Hatfield M, Rome L, Rubin J, Kirn D. 2002. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl 1520): phase II viral, immunologic, and clinical endpoints. Cancer Res 62:6070-6079.
18. Hamid O, Varterasian ML, Wadler S, Hecht JR, Benson A, Galanis E, Uprichard M, Omer C, Bycott P, Hackman RC, Shields AF. 2003. Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer. J Clin Oncol 21:1498-1504. http://dx.doi.org/10.1200/JCO.2003.09.114.
19. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, Denby L, Kemball-Cook G, Ni S, Lieber A, McVey JH, Nicklin SA, Baker AH. 2006. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108: 2554-2561. http://dx.doi.org/10.1182/blood-2006-04-008532.
20. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SMK, Greig JA, Denby L, Custers J, Morita T, Francischetti IMB, Monteiro RQ, Barouch DH, van Rooijen N, Napoli C, Havenga MJE, Nicklin SA, Baker AH. 2008. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397-409. http://dx.doi.org/10.1016/j.cell.2008.01.016.
21. Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T, Byrnes AP. 2013. Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med 19:452-457. http://dx.doi.org/10.1038/nm.3107.
22. Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A. 2000. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells 1. J Immunol 164:5998-6004. http://dx.doi.org/10.4049/jimmunol.164.11.5998.
23. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. 2009. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMPdependent protein kinase pathway. J Immunol 182:7997-8004. http://dx.doi.org/10.4049/jimmunol.0802884.
24. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. 2005. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 83:196-198. http://dx.doi.org/10.1111/j.1440-1711.2005.01314.x.
25. Dunzendorfer S, Lee H-K, Soldau K, Tobias PS. 2004. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J 18:1117-1119. http://dx.doi.org/10.1096/fj.03-1263fje.
26. Fernandes-Alnemri T, Wu J, Yu J-W, Datta P, Miller B, Jankowski W, Rosenberg S, Zhang J, Alnemri E. 2007. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14:1590-1604. http://dx.doi.org/10.1038/sj.cdd.4402194.
27. Berges C, Naujokat C, Tinapp S, Wieczorek H, Höh A, Sadeghi M, Opelz G, Daniel V. 2005. A cell line model for the differentiation of human dendritic cells. Biochem Biophys Res Commun 333:896-907. http://dx.doi.org/10.1016/j.bbrc.2005.05.171.
28. Kremer EJ, Boutin S, Chillon M. 2000. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 74:505-512. http://dx.doi.org/10.1128/JVI.74.1.505-512.2000.
29. Glotzer JB, Michou A, Baker A, Saltik M, Cotten M. 2001. Microtubule-Independent motility and nuclear targeting of adenoviruses with fluorescently labeled genomes. J Virol 75:2421-2434. http://dx.doi.org/10.1128/JVI.75.5.2421-2434.2001.
30. Soudais C, Boutin S, Hong SS, Danos O, Bergelson JM, Kremer EJ, Hong S, Chillon M, Boulanger P. 2000. Canine adenovirus type 2 attachment and receptor, alternative receptors, and an RGD-independent pathway. J Virol 74:10639-10649. http://dx.doi.org/10.1128/JVI.74.22.10639-10649.2000.
31. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
32. Ohashi K, Burkart V, Flohe S, Kolb H. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J Immunol 164:558-561. http://dx.doi.org/10.4049/jimmunol.164.2.558.
33. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz BS, Geurts J, Wunderink LU, Schreurs BW, van den Berg WB, Radstake TRDJ. 2006. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 176:7021-7027. http://dx.doi.org/10.4049/jimmunol.176.11.7021.
34. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim J-Y, Strassheim D, Sohn J-W, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E. 2006. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917-C924. http://dx.doi.org/10.1152/ajpcell.00401.2005.
35. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. 2011. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147:868-880. http://dx.doi.org/10.1016/j.cell.2011.09.051.
36. Danielsson A, Elgue G, Nilsson BM, Nilsson B, Lambris JD, Tötterman TH, Kochanek S, Kreppel F, Essand M. 2010. An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood. Gene Ther 17:752-762. http://dx.doi.org/10.1038/gt.2010.18.
37. Kirn D. 2001. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther 8:89-98. http://dx.doi.org/10.1038/sj.gt.3301377.
38. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat Immunol 9:361-368. http://dx.doi.org/10.1038/ni1569.
39. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166:249-255. http://dx.doi.org/10.4049/jimmunol.166.1.249.
40. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168: 4531-4537. http://dx.doi.org/10.4049/jimmunol.168.9.4531.
41. Davison AJ, Benko M, Harrach B. 2003. Genetic content and evolution of adenoviruses. J Gen Virol 84:2895-2908. http://dx.doi.org/10.1099/vir.0.19497-0.
42. Shortman K, Liu Y-J. 2002. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151-161. http://dx.doi.org/10.1038/nri746.
43. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189:1777-1782. http://dx.doi.org/10.1084/jem.189.11.1777.
44. Rallabhandi P, Phillips RL, Marina S. 2012. Respiratory syncytial virus fusion protein-induced Toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. mBio 3:e00218-12. http://dx.doi.org/10.1128/mBio.00218-12.
45. Deguchi A, Tomita T, Omori T, Komatsu A, Ohto U, Takahashi S, Tanimura N, Akashi-Takamura S, Miyake K, Maru Y. 2013. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner. J Immunol 191:1856-1864. http://dx.doi.org/10.4049/jimmunol.1201996.
46. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S, Aburatani H, Maru Y. 2008. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a premetastatic phase. Nat Cell Biol 10:1349-1355. http://dx.doi.org/10.1038/ncb1794.
47. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B. 2000. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 1:research002.1-research002.10. http://dx.doi.org/10.1186/gb-2000-1-1-research002.
48. Vasl J, Oblak A, Gioannini TL, Weiss JP, Jerala R. 2009. Novel roles of lysines 122, 125, and 58 in functional differences between human and murine MD-2. J Immunol 183:5138-5145. http://dx.doi.org/10.4049/jimmunol.0901544.
49. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M. 2000. Mouse Toll-like receptor 4MD-2complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 275:2251-2254. http://dx.doi.org/10.1074/jbc.275.4.2251.
50. Ohto U, Fukase K, Miyake K, Shimizu T. 2012. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Natl Acad Sci USA 109:7421-7426. http://dx.doi.org/10.1073/pnas.1201193109.
51. Steeghs L, Keestra A, van Mourik MA, Uronen-Hansson H, van der Ley P, Callard R, Klein N, van Putten JPM. 2008. Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect Immun 76:3801-3807. http://dx.doi.org/10.1128/IAI.00005-08.
52. Schroder K, Irvine KM, Taylor MS, Bokil NJ, Le Cao K-A, Masterman K-A, Labzin LI, Semple CA, Kapetanovic R, Fairbairn L, Akalin A, Faulkner GJ, Baillie JK, Gongora M, Daub CO, Kawaji H, McLachlan GJ, Goldman N, Grimmond SM, Carninci P, Suzuki H, Hayashizaki Y, Lenhard B, Hume DA, Sweet MJ. 2012. Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci USA 109:E944-E953. http://dx.doi.org/10.1073/pnas.1110156109.
53. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D, Inflammation and the Host Response to Injury Investigators. 2005. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12:60-67. http://dx.doi.org/10.1128/CDLI.12.1.60-67.2005.
54. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. 2002. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3:354-359. http://dx.doi.org/10.1038/ni777.
55. Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, Pichyangkul S, Ruxrungtham K. 2008. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Vet Immunol Immunopathol 125:18-30. http://dx.doi.org/10.1016/j.vetimm.2008.05.001.
56. Zaiss AK, Lawrence R, Elashoff D, Esko JD, Herschman HR. 2011. Differential effects of murine and human factor X on adenovirus transduction via cell-surface heparan sulfate. J Biol Chem 286:24535-24543. http://dx.doi.org/10.1074/jbc.M111.241562.
57. Lenaerts L, van Dam W, Persoons L, Naesens L. 2012. Interaction between mouse adenovirus type 1 and cell surface heparan sulfate proteoglycans. PLoS One 7:e31454. http://dx.doi.org/10.1371/journal.pone.0031454.
58. Lenaerts L, Mcvey JH, Baker AH, Denby L, Nicklin S, Verbeken E, Naesens L. 2009. Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting. J Gene Med 11:119-127. http://dx.doi.org/10.1002/jgm.1283.
59. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG, Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad SciUSA110:3507-3512. http://dx.doi.org/10.1073/pnas.1222878110.
60. Takao K, Miyakawa T. 3 August 2014. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad SciUSA http://dx.doi.org/10.1073/pnas.1401965111.
61. Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, Kolde R, Peterson H, Vilo J, Peterson P, Rebane A. 2011. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 286:26487-26495. http://dx.doi.org/10.1074/jbc.M110.213561.
62. Perreau M, Guérin M-C, Drouet C, Kremer EJ. 2007. Interactions between human plasma components and a xenogenic adenovirus vector: reduced immunogenicity during gene transfer. Mol Ther 15:1998-2007. http://dx.doi.org/10.1038/sj.mt.6300289.
63. Perreau M, Kremer EJ. 2005. Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus. J Virol 79: 14595-14605. http://dx.doi.org/10.1128/JVI.79.23.14595-14605.2005.